Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche forms 21-site I/O R&D network, commits $100M
Fierce Biotech
Tue, 11/15/16 - 10:10 am
Tags:
Roche, R&D
Roche flags early success for Tecentriq combos, hustles into PhIIIs
Endpoints
Mon, 11/7/16 - 09:10 pm
Tags:
Tecentriq, Roche, clinical trials, melanoma
Safety issues with Roche drug good for Novo Nordisk
BioPharma Dive
Thu, 11/3/16 - 01:30 pm
Tags:
Roche, Novo Nordisk, ACE910, emicizumab, hemophilia
If Roche's Ocrevus is approved, the already competitive MS market will gain another player
Medical Marketing and Media
Mon, 10/24/16 - 11:54 pm
Tags:
Roche, Ocrevus, MS, multiple sclerosis
With no big M&A on tap, Novartis presses pause on $12B-plus Roche stake sale
Fierce Pharma
Mon, 10/24/16 - 11:51 pm
Tags:
Novartis, M&A, Roche
Roche adjusts Avastin franchise defense plans as PhII successor fails a key study
Endpoints
Fri, 10/21/16 - 10:01 am
Tags:
Roche, Avastin, Vanucizumab
Earnings guide: A preview of 9 big pharmas in Q3
BioPharma Dive
Wed, 10/19/16 - 11:52 am
Tags:
earnings, Roche, Merck, Eli Lilly, Novartis, GSK, Bristol-Myers Squibb, Sanofi, Pfizer, AstraZeneca
Roche's lung cancer drug wins U.S. approval
Yahoo/Reuters
Tue, 10/18/16 - 10:27 pm
Tags:
Roche, lung cancer, FDA, Tecentriq, non-small cell lung cancer
Clinical trial roundup 2015 (infographic)
CP Wire
Tue, 10/18/16 - 10:01 am
Tags:
clinical trials, AstraZeneca, Roche, JNJ, oncology
Roche, AbbVie: Venclyxto Receives Positive Opinion From Committee
Yahoo/GuruFocus
Sat, 10/15/16 - 12:23 pm
Tags:
Roche, AbbVie, Venclyxto, CHMP, chronic lymphocytic leukemia, CLL, venetoclax
Roche lung cancer drug success adds to pressure on Bristol
Yahoo/Reuters
Mon, 10/10/16 - 09:14 am
Tags:
Roche, lung cancer, Tecentriq
3 Critical FDA Decisions You Can't Afford to Miss
Motley Fool
Tue, 09/27/16 - 10:13 pm
Tags:
FDA, Orkambi, Vertex Pharmaceuticals, Roche, Tecentriq, Regeneron, Sanofi, Sarilumab
Novartis's Zykadia gets positive results, faces Roche pressure
Yahoo/Reuters
Fri, 09/23/16 - 10:07 pm
Tags:
Novartis, Zykadia, Roche, non-small cell lung cancer
Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA
Endpoints
Fri, 09/23/16 - 11:47 am
Tags:
Novartis, Zykadia, non-small cell lung cancer, Roche, JNJ, GSK, rheumatoid arthritis, sirukumab
Roche To Topple Novartis As Industry's Biggest Seller
Seeking Alpha
Sun, 09/18/16 - 10:03 am
Tags:
Roche, Novartis, drug sales
Roche’s megablockbuster MS candidate ocrelizumab posts promising head-to-head data
Endpoints
Wed, 09/14/16 - 11:42 pm
Tags:
Roche, MS, multiple sclerosis, ocrelizumab
Roche's Tecentriq ready to compete in lung cancer
BioPharma Dive
Fri, 09/2/16 - 09:36 am
Tags:
Roche, Tecentriq, non-small cell lung cancer
Roche launches next-gen glucose monitor
Mass Device
Wed, 08/24/16 - 05:41 pm
Tags:
Roche, devices, diabetes, blood glucose monitoring
Roche, Eleven Bio eye the ocular market
BioPharma Dive
Fri, 08/19/16 - 11:48 am
Tags:
Roche, Eleven Biotherapeutics, EBI-031, interleukin-6
Can Eleven Biotherapeutics Keep Climbing With This Roche Deal?
24/7 Wall St
Wed, 08/17/16 - 10:40 am
Tags:
Eleven Biotherapeutics, Roche, EBI-031, interleukin-6, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.